(+)-schisandrin B multiple interactions ISO RGD:1359113 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CDV3 mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of CDV3 mRNA CTD PMID:28960355 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CDV3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CDV3 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDV3 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO RGD:1602107 6480464 Estradiol results in increased expression of CDV3 mRNA CTD PMID:19167446 more ... 17beta-estradiol multiple interactions ISO RGD:1602107 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CDV3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1602107 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of CDV3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDV3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDV3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CDV3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1602107 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDV3 mRNA CTD PMID:19619570 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602107 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1602107 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of CDV3 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of CDV3 mRNA CTD PMID:28973697 acetamide decreases expression ISO RGD:1359113 6480464 acetamide results in decreased expression of CDV3 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1602107 6480464 Aflatoxin B1 results in increased expression of CDV3 mRNA CTD PMID:27153756 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CDV3 mRNA CTD PMID:16788091 antirheumatic drug decreases expression ISO RGD:1602107 6480464 Antirheumatic Agents results in decreased expression of CDV3 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl 54% Chlorine results in decreased expression of CDV3 mRNA CTD PMID:23650126 arsenite(3-) affects expression ISO RGD:1602107 6480464 arsenite affects the expression of CDV3 mRNA CTD PMID:22959463 arsenous acid increases expression ISO RGD:1602107 6480464 Arsenic Trioxide results in increased expression of CDV3 mRNA CTD PMID:17258074 benzo[a]pyrene decreases expression EXP 6480464 Benzoapyrene results in decreased expression of CDV3 mRNA CTD PMID:21715664 benzo[a]pyrene affects methylation ISO RGD:1602107 6480464 Benzoapyrene affects the methylation of CDV3 3' UTR CTD PMID:27901495 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of CDV3 mRNA] CTD PMID:19850644 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CDV3 mRNA CTD PMID:19850644 bisphenol A decreases expression ISO RGD:1359113 6480464 bisphenol A results in decreased expression of CDV3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1359113 6480464 bisphenol A results in increased expression of CDV3 mRNA CTD PMID:30816183 bisphenol A affects expression ISO RGD:1602107 6480464 bisphenol A affects the expression of CDV3 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1602107 6480464 bisphenol A results in decreased expression of CDV3 mRNA CTD PMID:29275510 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of CDV3 promoter CTD PMID:27312807 bisphenol F multiple interactions ISO RGD:1602107 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA CTD PMID:28628672 Brodifacoum decreases expression ISO RGD:1359113 6480464 bromfenacoum results in decreased expression of CDV3 protein CTD PMID:28903499 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chromium(6+) affects expression EXP 6480464 chromium hexavalent ion affects the expression of CDV3 mRNA CTD PMID:28472532 cisplatin decreases expression ISO RGD:1602107 6480464 Cisplatin results in decreased expression of CDV3 mRNA CTD PMID:27594783 cisplatin multiple interactions ISO RGD:1602107 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of CDV3 mRNA CTD PMID:27392435 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA] CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1359113 6480464 cobaltous chloride results in increased expression of CDV3 mRNA CTD PMID:24386269 copper atom multiple interactions EXP 6480464 MT1 affects the reaction [Copper results in increased expression of CDV3 mRNA], MT2 affects the reaction [Copper results in increased expression of CDV3 mRNA] CTD PMID:16629173 copper(0) multiple interactions EXP 6480464 MT1 affects the reaction [Copper results in increased expression of CDV3 mRNA], MT2 affects the reaction [Copper results in increased expression of CDV3 mRNA] CTD PMID:16629173 copper(II) sulfate increases expression ISO RGD:1602107 6480464 Copper Sulfate results in increased expression of CDV3 mRNA CTD PMID:19549813 coumestrol increases expression ISO RGD:1602107 6480464 Coumestrol results in increased expression of CDV3 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1602107 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:1602107 6480464 Asbestos, Crocidolite results in increased expression of CDV3 mRNA CTD PMID:29523930 cyclosporin A increases expression ISO RGD:1602107 6480464 Cyclosporine results in increased expression of CDV3 mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone multiple interactions ISO RGD:1602107 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO RGD:1602107 6480464 Arsenic Trioxide results in increased expression of CDV3 mRNA CTD PMID:17258074 dibutyl phthalate increases expression ISO RGD:1359113 6480464 Dibutyl Phthalate results in increased expression of CDV3 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1602107 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CDV3 mRNA CTD PMID:27188386 doxorubicin increases expression ISO RGD:1602107 6480464 Doxorubicin results in increased expression of CDV3 mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:1359113 6480464 Endosulfan results in increased expression of CDV3 mRNA CTD PMID:29391264 entinostat multiple interactions ISO RGD:1602107 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CDV3 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:1602107 6480464 Ethyl Methanesulfonate results in decreased expression of CDV3 mRNA CTD PMID:23649840 flutamide increases expression ISO RGD:1359113 6480464 Flutamide results in increased expression of CDV3 mRNA CTD PMID:24136188 formaldehyde decreases expression ISO RGD:1602107 6480464 Formaldehyde results in decreased expression of CDV3 mRNA CTD PMID:23649840 fumonisin B1 increases expression EXP 6480464 fumonisin B1 results in increased expression of CDV3 mRNA CTD PMID:16221962 indoles decreases expression ISO RGD:1359113 6480464 Indoles results in decreased expression of CDV3 mRNA CTD PMID:20521778 indoles increases expression ISO RGD:1359113 6480464 Indoles results in increased expression of CDV3 mRNA CTD PMID:20521778 indometacin multiple interactions ISO RGD:1602107 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis4-hydroxyphenylsulfone] results in increased expression of CDV3 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDV3 mRNA CTD PMID:28628672 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of CDV3 mRNA CTD PMID:20003209 methyl methanesulfonate decreases expression ISO RGD:1602107 6480464 Methyl Methanesulfonate results in decreased expression of CDV3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1602107 6480464 methylmercuric chloride results in increased expression of CDV3 mRNA CTD PMID:28001369 paracetamol decreases expression ISO RGD:1602107 6480464 Acetaminophen results in decreased expression of CDV3 mRNA CTD PMID:22230336 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CDV3 mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CDV3 mRNA CTD PMID:17562736 perfluorooctanoic acid increases expression ISO RGD:1602107 6480464 perfluorooctanoic acid results in increased expression of CDV3 protein CTD PMID:22609092 phenobarbital affects expression ISO RGD:1602107 6480464 Phenobarbital affects the expression of CDV3 mRNA CTD PMID:19159669 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CDV3 mRNA CTD PMID:16221962 resveratrol multiple interactions ISO RGD:1602107 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CDV3 mRNA CTD PMID:19167446 SB 431542 multiple interactions ISO RGD:1602107 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of CDV3 mRNA CTD PMID:27188386 sodium dichromate increases expression ISO RGD:1359113 6480464 sodium bichromate results in increased expression of CDV3 mRNA CTD PMID:25993096 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of CDV3 protein CTD PMID:28918527 sunitinib increases expression ISO RGD:1602107 6480464 Sunitinib results in increased expression of CDV3 mRNA CTD PMID:31533062 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of CDV3 mRNA CTD PMID:17555576 tetrachloromethane multiple interactions ISO RGD:1359113 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of CDV3 mRNA] CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1359113 6480464 Carbon Tetrachloride results in increased expression of CDV3 mRNA CTD PMID:31150632 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of CDV3 mRNA CTD PMID:23557971 trichostatin A affects expression ISO RGD:1602107 6480464 trichostatin A affects the expression of CDV3 mRNA CTD PMID:28542535 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CDV3 mRNA CTD PMID:19042947 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CDV3 mRNA CTD PMID:21427059 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CDV3 mRNA CTD PMID:17292431 valproic acid affects expression ISO RGD:1602107 6480464 Valproic Acid affects the expression of CDV3 mRNA CTD PMID:25979313 zoledronic acid increases expression ISO RGD:1602107 6480464 zoledronic acid results in increased expression of CDV3 mRNA CTD PMID:20977926 
